Active-ingredient Dossier
Ambrisentan
Active-ingredient Dossier for Ambrisentan (endothelin receptor antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: VOLIBRIS
- Brand: AMBRISENTAN VIATRIS
- Brand: PULMORIS
- Brand: AMBRICIP
- Brand: AMBRISENTAN MSN
- Brand: AMBRISENTAN SANDOZ
- Therapeutic area: Cardiology
What is
Ambrisentan Ambrisentan is an endothelin receptor antagonist.
Australian brands containing Ambrisentan
— VOLIBRIS — AMBRISENTAN VIATRIS — PULMORIS — AMBRICIP — AMBRISENTAN MSN — AMBRISENTAN SANDOZ
Therapeutic areas
Ambrisentan is registered in cardiology, with 6 brands containing the ingredient on the ARTG.
Sponsor landscape
Ambrisentan is marketed by five sponsors: Cipla, Accelagen, Sandoz, Alphapharm, and GlaxoSmithKline.
PBS and regulatory activity
The latest PBAC outcome for ambrisentan was recorded on 1 July 2009, and the latest AusPAR was issued on 9 February 2016.